Optimus Drugs Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and WHO-GMP.
One of their notable products is SOLIFENACIN SUCCINATE, with a corresponding US DMF Number 30965.
Remarkably, this DMF maintains an Active status since its submission on December 09, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 30, 2017, and payment made on September 29, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II